Brain Mechanisms of Reducing Polysubstance Use Following a Novel Body-mind Intervention

Multiple Drug Use Clinical Trial

Official title:
Brain Mechanisms of Reducing Polysubstance Use Following a Novel Body-mind Intervention

Status Completed

Clinical Trial Summary

The proposed study will examine brain mechanisms of a brief mindfulness intervention - integrative body-mind training (IBMT) on alcohol, tobacco, and cannabis (ATC) reduction.

Clinical Trial Description

The R61 phase of the proposed study will examine brain mechanisms of a brief mindfulness intervention - integrative body-mind training (IBMT) that targets at self-control networks in the brain, and test IBMT effects on alcohol, tobacco, and cannabis (ATC) reduction. ;

Study Design

Related Conditions & MeSH terms

Multiple Drug Use

Clinical Trial Details

NCT number	NCT04261504
Study type	Interventional
Source	Texas Tech University
Contact
Status	Completed
Phase	N/A
Start date	April 19, 2019
Completion date	February 28, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT06214130` - Bioavailability of Orfiril Long 500 mg Prolonged-Release Minitablets and Ergenyl Chrono 500 mg Prolonged-Release Tablets	Phase 1
Recruiting	`NCT06324786` - Brain Mechanisms of Reducing Polysubstance Use	N/A
Completed	`NCT01689493` - Strategy to Improve Antiplatelet Therapy Adherence After Coronary Stent Implantation	N/A
Recruiting	`NCT01758679` - A Clinical Trail of Iodine[131I] Metuximab Injection With CIK Cells for Preventing Hepatocellular Carcinoma	Phase 4